相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The challenge of drugging undruggable targets in cancer: Lessons learned from targeting BCL-2 family members
Gregory L. Verdine et al.
CLINICAL CANCER RESEARCH (2007)
X-linked inhibitor of apoptosis protein as a therapeutic target
Emma J. Dean et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy
Seok Yun Kang et al.
CLINICAL CANCER RESEARCH (2007)
c-FLIP: A key regulator of colorectal cancer cell death
Timothy R. Wilson et al.
CANCER RESEARCH (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity
Alicia B. Berger et al.
CELL RESEARCH (2006)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis
Eric C. LaCasse et al.
CLINICAL CANCER RESEARCH (2006)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP
L Galligan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
ML Hyer et al.
CANCER RESEARCH (2005)
Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage
VC Broaddus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome
MB Valnet-Rabier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells
JM Cummins et al.
CANCER RESEARCH (2004)
c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis
S Mathas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells
J Han et al.
LEUKEMIA (2004)
Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human Esophageal epithelial cells
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
D Arango et al.
BRITISH JOURNAL OF CANCER (2004)
Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway
C von Haefen et al.
ONCOGENE (2004)
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis
I Tamm et al.
HEMATOLOGY JOURNAL (2004)
Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy
SL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Defining characteristics of Types I and II apoptotic cells in response to TRAIL
N Özören et al.
NEOPLASIA (2002)
TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid
AB Werner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
F Guo et al.
BLOOD (2002)
Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein
XM Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer
A Jansson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
TRAIL-induced apoptosis requires Bax-dependent mitochondria release of Smac/DIABLO
YB Deng et al.
GENES & DEVELOPMENT (2002)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
Increased expression of cFLIPL in colonic adeno carcinoma
BK Ryu et al.
JOURNAL OF PATHOLOGY (2001)
Role of BAX in the apoptotic response to anticancer agents
L Zhang et al.
SCIENCE (2000)
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
JJ Chai et al.
NATURE (2000)
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
CY Du et al.
CELL (2000)
Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
WC Yeh et al.
IMMUNITY (2000)
Mitochondrial control of cell death
G Kroemer et al.
NATURE MEDICINE (2000)
分享论文
